Nido Biosciences Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Out of Business

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Out of Business

Nido Biosciences General Information

Description

Developer of a healthcare platform intended to develop precision medicines and small-molecule therapeutics to treat neurodegenerative diseases. The company uses a functional genomics discovery platform based on human cell lines that leverages tailored screens to identify novel therapeutic targets for multiple neuromuscular and neurodegenerative diseases and human genetics, enabling healthcare professionals to treat the underlying biology of disease and restore healthy cell function to create precise medications.

Contact Information

Website
www.nidobio.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 59 West Dedham Street
  • Unit 180430
  • Boston, MA 02118
  • United States
+1 (857)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
Corporate Office
  • 59 West Dedham Street
  • Unit 180430
  • Boston, MA 02118
  • United States
+1 (857)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nido Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Out of Business 30-Dec-2025 Completed Out of Business
6. Later Stage VC Completed Clinical Trials - Phase 1
5. Later Stage VC (Series B) 15-May-2023 Completed Clinical Trials - Phase 1
4. Early Stage VC (Series A1) 29-Nov-2022 Completed Clinical Trials - Phase 1
3. Early Stage VC (Series A) 08-Sep-2020 Completed Clinical Trials - Phase 1
2. Seed Round 10-Sep-2019 $4M $4M Completed Clinical Trials - Phase 1
1. University Spin-Out 01-Jan-2018 Completed Startup
To view Nido Biosciences’s complete valuation and funding history, request access »

Nido Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B-1
Series B
Series A-1 37,000,000 $0.000100 $0.1 $1.25 $1.25 1x $1.25 33.71%
Seed 4,000,000 $0.000100 $0.08 $1 $1 1x $1 3.64%
To view Nido Biosciences’s complete cap table history, request access »

Nido Biosciences Patents

Nido Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250263396-A1 Crystalline forms of 3-(5-(2-hydroxy-2- methylpropoxy)-6-methypyrazin-2-yl)-1h-indole-7-carbonitrile Pending 26-Jan-2024
WO-2025160320-A1 Crystalline forms of 3-(5-(2-hydroxy-2-methylpropoxy)-6-methylpyrazin-2-yl)-1h-indole-7-carbonitrile Pending 26-Jan-2024
AU-2023206373-A1 Crystalline forms of 3-(5-(2-hydroxy-2-methylpropoxy)-6-methylpyrazin-2-yl)-1h-indole-7-carbonitrile Pending 14-Jan-2022
EP-4463449-A1 Crystalline forms of 3-(5-(2-hydroxy-2-methylpropoxy)-6-methylpyrazin-2-yl)-1h-indole-7-carbonitrile Inactive 14-Jan-2022
US-12168650-B2 Crystalline forms of 3-(5-(2-hydroxy-2-methylpropoxy)-6-methylpyrazin-2-yl)-1h-indole-7-carbonitrile Active 14-Jan-2022 C07D401/04
To view Nido Biosciences’s complete patent history, request access »

Nido Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nido Biosciences FAQs

  • When was Nido Biosciences founded?

    Nido Biosciences was founded in 2018.

  • Where is Nido Biosciences headquartered?

    Nido Biosciences is headquartered in Boston, MA.

  • What is the size of Nido Biosciences?

    Nido Biosciences has 11 total employees.

  • What industry is Nido Biosciences in?

    Nido Biosciences’s primary industry is Drug Discovery.

  • Is Nido Biosciences a private or public company?

    Nido Biosciences is a Private company.

  • What is Nido Biosciences’s current revenue?

    The current revenue for Nido Biosciences is .

  • How much funding has Nido Biosciences raised over time?

    Nido Biosciences has raised $109M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process